You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Prescription charges affect medicine usage on the medical card scheme – study

By Dermot - 19th Feb 2016 | 2 views

The study, funded by the Health Research Board, and co-authored by researchers in University College Cork (UCC) and Trinity College Dublin,<em><strong> </strong></em>tracked<strong> </strong>how the 50c and €1.50 prescription charges impacted on how patients take their medications.

Using anonymised data from the national pharmacy claims database, which holds data on every single prescription filled in the medical card population, the authors found that after the 50c prescription charge in 2010, adherence of all medicines included in the study was reduced. The reduction ranged from 2 per cent to 5 per cent for most essential medicines. The exception was anti-depressant medicines which dropped by 8 per cent. The reduction in adherence to less-essential medicines ranged from 2 per cent to 10 per cent.

After the €1.50 charge, the reduction in adherence to most essential medicines was generally smaller than seen for the 50c charge, except for anti-depressant medicines which dropped by 10 per cent. In contrast, the reduction in adherence to less-essential medicines was larger after the €1.50 charge than seen after the 50c charge, except for sedative and anti-anxiety medicines where a drop of less than 1 per cent was seen.

Lead author, Dr Sarah-Jo Sinnott, who conducted this research as a research pharmacist and PhD student on the HRB Scholars Programme in Health Services Research based in the Department of Epidemiology and Public Health, UCC, commented: “We found that the charges had a larger impact on whether people continued to take ‘less-essential’ medicines such as painkillers and medicines used to treat stomach acid than it did on people taking “essential” medicines, such as those which lower blood pressure and cholesterol or for diabetes. The exception to this pattern was that large reductions in the use of anti-depressant medicines were found.”

Prof Helen Whelton, senior author of the paper and now Dean of the School of Dentistry, University of Leeds, UK, said the study, which was published in the journal<em> Pharmacoepidemiology and Drug Safety</em>, provides good evidence for policy makers to help understand how prescription charges affected medication use.

“Now that we know the extent to which these charges have affected medication adherence, we need to assess if there has been an impact on health outcomes such as heart attacks and stroke in the Irish medical card population. The findings concerning medication use in depression also require further research, as does the new increased charge of €2.50 per prescription item. The information presented in this paper demonstrates the potential of routinely collected data to answer important policy questions for patient benefit. The development of health services research, such as this, has the potential to contribute to smarter, patient centred health policy and more effective and efficient health services in the future.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]